Form 4: Director Michael Fucci Receives Acadia Healthcare Equity

Director Michael Fucci acquired 6,331 shares of Acadia Healthcare Company, Inc. common stock as part of an equity grant.

Summary

• Director Michael Fucci was granted 6,331 shares of common stock in Acadia Healthcare Company, Inc. (ACHC).
• The transaction occurred on May 6, 2026.
• The shares were acquired at a price of $0.00, representing an equity compensation grant.
• Following this transaction, the director's total beneficial ownership is 28,152 shares.
• The granted shares are subject to a 3-year vesting schedule with equal annual installments starting May 6, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.

Positives

• Alignment of director interests with shareholders through equity ownership.
• Retention of board leadership via multi-year vesting schedule.

Negatives

• None identified; this is a standard equity compensation disclosure.

Risks

• None identified; this is a standard equity compensation disclosure.

Future Outlook

The shares are subject to a 3-year vesting period, indicating a long-term commitment by the director to the company's performance.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board members maintain a vested interest in the long-term performance of the company.

Comparison to Industry Standards

• The use of a 3-year vesting schedule for director equity is consistent with standard corporate governance practices in the healthcare services sector.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity grant.

Next Steps

• Vesting of the first installment of shares on May 6, 2027.

Key Dates

Keywords

Acadia Healthcare, ACHC, Form 4, Insider Transaction, Director Equity, Stock Grant